ID

16206

Beschreibung

Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00065533

Link

https://clinicaltrials.gov/show/NCT00065533

Stichworte

  1. 05.07.16 05.07.16 -
Hochgeladen am

5. Juli 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT00065533

Eligibility Breast Cancer NCT00065533

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
be at least 18 years of old.
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
have been diagnosed with breast cancer
Beschreibung

Breast Carcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0678222
at least one year disease-free interval after initial treatment.
Beschreibung

Status post Therapeutic procedure Initial | Interval Disease Free

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0231290
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0205265
UMLS CUI [2,1]
C1272706
UMLS CUI [2,2]
C0012634
UMLS CUI [2,3]
C0332296
have pre-study laboratory tests that are within the requirements of this study.
Beschreibung

Laboratory test finding Study Protocol suitable

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0587081
UMLS CUI [1,2]
C2348563
UMLS CUI [1,3]
C3900053
be able to visit the doctor's office weekly during the treatment period.
Beschreibung

Ability Visit Doctor's Office

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0085732
UMLS CUI [1,2]
C0545082
UMLS CUI [1,3]
C0031834
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
to be pregnant or breastfeeding.
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
to be currently taking aspirin or aspirin- like medicine and unable to stop for a few days during each cycle of therapy.
Beschreibung

taking aspirin | Intake Aspirin-Like Agents | medication stopping Unable

Datentyp

boolean

Alias
UMLS CUI [1]
C2054131
UMLS CUI [2,1]
C1512806
UMLS CUI [2,2]
C0085847
UMLS CUI [3,1]
C0850893
UMLS CUI [3,2]
C1299582
to have received prior chemotherapy for the treatment of metastatic cancer. patients may have received prior hormonal treatment.
Beschreibung

Prior Chemotherapy Metastatic Neoplasm | Prior Hormone Therapy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C2939420
UMLS CUI [2]
C1514460
to have another illness that your doctor thinks would make you unable to participate.
Beschreibung

Comorbidity Study Subject Participation Status Limited

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C2348568
UMLS CUI [1,3]
C0439801
to be unable or not willing to take folic acid and vitamin b12.
Beschreibung

Unable to take Folic Acid | Unable to take Vitamin B 12 | Intake Folic Acid Unwilling | Intake Vitamin B 12 Unwilling

Datentyp

boolean

Alias
UMLS CUI [1,1]
C4074979
UMLS CUI [1,2]
C0016410
UMLS CUI [2,1]
C4074979
UMLS CUI [2,2]
C0042845
UMLS CUI [3,1]
C1512806
UMLS CUI [3,2]
C0016410
UMLS CUI [3,3]
C0558080
UMLS CUI [4,1]
C1512806
UMLS CUI [4,2]
C0042845
UMLS CUI [4,3]
C0558080

Ähnliche Modelle

Eligibility Breast Cancer NCT00065533

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
be at least 18 years of old.
boolean
C0001779 (UMLS CUI [1])
Breast Carcinoma
Item
have been diagnosed with breast cancer
boolean
C0678222 (UMLS CUI [1])
Status post Therapeutic procedure Initial | Interval Disease Free
Item
at least one year disease-free interval after initial treatment.
boolean
C0231290 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0205265 (UMLS CUI [1,3])
C1272706 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C0332296 (UMLS CUI [2,3])
Laboratory test finding Study Protocol suitable
Item
have pre-study laboratory tests that are within the requirements of this study.
boolean
C0587081 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C3900053 (UMLS CUI [1,3])
Ability Visit Doctor's Office
Item
be able to visit the doctor's office weekly during the treatment period.
boolean
C0085732 (UMLS CUI [1,1])
C0545082 (UMLS CUI [1,2])
C0031834 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
to be pregnant or breastfeeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
taking aspirin | Intake Aspirin-Like Agents | medication stopping Unable
Item
to be currently taking aspirin or aspirin- like medicine and unable to stop for a few days during each cycle of therapy.
boolean
C2054131 (UMLS CUI [1])
C1512806 (UMLS CUI [2,1])
C0085847 (UMLS CUI [2,2])
C0850893 (UMLS CUI [3,1])
C1299582 (UMLS CUI [3,2])
Prior Chemotherapy Metastatic Neoplasm | Prior Hormone Therapy
Item
to have received prior chemotherapy for the treatment of metastatic cancer. patients may have received prior hormonal treatment.
boolean
C1514457 (UMLS CUI [1,1])
C2939420 (UMLS CUI [1,2])
C1514460 (UMLS CUI [2])
Comorbidity Study Subject Participation Status Limited
Item
to have another illness that your doctor thinks would make you unable to participate.
boolean
C0009488 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,3])
Unable to take Folic Acid | Unable to take Vitamin B 12 | Intake Folic Acid Unwilling | Intake Vitamin B 12 Unwilling
Item
to be unable or not willing to take folic acid and vitamin b12.
boolean
C4074979 (UMLS CUI [1,1])
C0016410 (UMLS CUI [1,2])
C4074979 (UMLS CUI [2,1])
C0042845 (UMLS CUI [2,2])
C1512806 (UMLS CUI [3,1])
C0016410 (UMLS CUI [3,2])
C0558080 (UMLS CUI [3,3])
C1512806 (UMLS CUI [4,1])
C0042845 (UMLS CUI [4,2])
C0558080 (UMLS CUI [4,3])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video